ReviewMikrochimica acta2025
Nano optical (bio)sensing platforms for early detection of pediatric cancer.
Review in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pediatric cancer refers to cancers that occur in children and adolescents, typically defined as those occuring under the age of 18. Although childhood cancers are relatively rare compared to adult cancers, they are a leading cause of death by disease in children. Early detection of childhood cancer is crucial for improving treatment outcomes and survival rates. To detect pediatric cancers in their early stages, the identification of biomarkers can be very helpful. Optical sensors and biosensors, as new analytical devices, can be used as a powerful and non-invasive tool to detect and quantify various cancer-specific biomarkers. Nanomaterials play a transformative role in the development of optical (bio)sensors, enhancing their sensitivity, specificity, and overall performance. Nano optical (bio)sensors provide a non-invasive, swift, and cost-effective method for the early detection of pediatric cancer by identifying cancer-related biomarkers.
Indexed as
Identifiers
40471347What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.